Ipca Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 to consider and approve Standalone and Consolidated Unaudited Results for Q2 H1FY24 and Interim Dividend.
The above information is a part of company’s filings submitted to BSE.